Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Estriol × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 258 Paclitaxel 215 Cyclophosphamide 173 Docetaxel 146 Letrozole 125 Capecitabine 121 Fulvestrant 120 Doxorubicin 111 Carboplatin 98 Bevacizumab 90 exemestane 88 Anastrozole 85 Tamoxifen 77 Lapatinib 77 pembrolizumab 67 Albumin-Bound Paclitaxel 67 pertuzumab 61 palbociclib 60 Taxes 59 Gemcitabine 57 eribulin 48 130-nm albumin-bound paclitaxel 47 Radiotherapy 44 Everolimus 44 Ado-Trastuzumab Emtansine 42 Vinorelbine 39 ixabepilone 32 Epirubicin 30 Cisplatin 30 pegfilgrastim 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02413008 2019-08-05

BLISSAFE

ITF Research Pharma, S.L.U.

Phase 2 Completed

61 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡